Genetic deletion or pharmacological ablation of 5-LO or LTA4H significantly reduces the tumor burden in K-ras–driven pancreatic ductal adenocarcinoma and in xenograft mouse model of human pancreatic cancer, through reduction of TNF-α secretion (Oi et al., 2010; Knab et al., 2015). This evidence concerns the gene TNF and neoplasm.